Skip to main content
. 2020 Nov 21;5(1):107–115. doi: 10.1002/jgh3.12456

Figure 3.

Figure 3

Proportion of all coronavirus disease (COVID)‐19 patients with elevated transaminases, by studies restricted to patients with respiratory symptoms or not. Overall prevalence of elevated transaminases in COVID‐19 infection was 24% (95% confidence interval 17–31%). This proportion was 33% in studies restricted to patients with respiratory symptoms, and only 21% in studies including patients without respiratory symptoms (P = 0.20).